“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with Persistent use,” says Stahl, a senior staff scientist in the Bohn lab. “This is the fascinating characteristic for possible use in the context of Long-term, significant pain.” HealingEnergy14 reported: https://9royalstreet.com/product/sr-17018-vendor/